Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease

Figures

• 

  Figure 1. Weighted Kaplan-Meier Curve for the Incidence of Alzheimer Disease During the Follow-Up Period PDE5I = phosphodiesterase type 5 inhibitor.

• 

  Figure 2. Forest Plot Summarizing the Results of Secondary and Sensitivity Analyses for the Association Between the Use of PDE5I and the Risk of Incident Alzheimer Disease PDE5I = phosphodiesterase type 5 inhibitor.

• 

  Figure 3. Forest Plot Summarizing the Results of Subgroup Analyses for the Association Between the Use of PDE5I and the Risk of Incident AD AD = Alzheimer disease; PDE5I = phosphodiesterase type 5 inhibitor.